Literature DB >> 446319

[Treatment of reflux oesophagitis with cimetidine (author's transl)].

G Lepsien, A Sonnenberg, W Berges, K B Weber, M Wienbeck, J R Siewert, A L Blum.   

Abstract

The effect of cimetidine on reflux oesophagitis was studied in a double-blind trial. Sixteen patients were given cimetidine 1.6 g/d, 20 patients received a placebo. Within the first six weeks the oesophagitis improved both on cimetidine and the placebo, but the patients taking the former had fewer complaints during the day than those on a placebo. Continuing the regimen for another six weeks further improved the endoscopic findings in patients with cimetidine but not in those on placebos. Complaints lessened during the sixth to twelfth week during cimetidine treatment, but remained unchanged under placebo administration. Complete healing of the oesophagitis was achieved in only 33% of patients with uncomplicated oesophagitis (grade I-III) and in 6% of those with severe complicated oesophagitis (grade IV). If non-surgical treatment is indicated, it must be continued through at least 6-12 weeks.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446319     DOI: 10.1055/s-0028-1104011

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Treatment of reflux oesophagitis with ranitidine.

Authors:  I C Wesdorp; W Dekker; E C Klinkenberg-Knol
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

2.  When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment.

Authors:  A Sonnenberg; G Lepsien; S A Müller-Lissner; H R Koelz; J R Siewert; A L Blum
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

3.  Cimetidine therapy for gastroesophageal reflux disease.

Authors:  A P Archambault; A Farley; I G Cleator; N B Hershfield; H Navert; E J Prokipchuk; A B Thomson
Journal:  West J Med       Date:  1985-11

4.  Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.

Authors:  G Vantrappen; L Rutgeerts; P Schurmans; J L Coenegrachts
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.